Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Adv Ther (Weinh). 2022 Oct 12;6(1):2200102. doi: 10.1002/adtp.202200102

Figure 3: Interfacial interactions of the MoNi polymer excipient in mAb formulations.

Figure 3:

(A) Comparison of PGT121 (0.2 mg/mL) with and without MoNi (0.1 mg/mL) in time resolved surface tension measurements (n=3). (B) Interfacial rheology measurements (n=3) of PGT121 (0.2 mg/mL) with and without MoNi (0.1 mg/mL). (C) High shear rate viscosity measurements collected at steady state by viscometry experiments for high concentration formulations of PGT121 (119 mg/mL) with and without MoNi (10 mg/mL).